Vertex Pharmaceuticals Appoints Jonathan Poole as New CFO, Effective January 2027

Vertex Pharmaceuticals announced the appointment of Jonathan Poole as its new Executive Vice President and Chief Financial Officer, effective January 1, 2027. Mr. Poole, currently the company's Senior Vice President of Finance, will succeed Charles F. Wagner, Jr. in the CFO role. Mr. Wagner will continue to serve as the company's Executive Vice President and Chief Operating Officer.

Key Details

• Appointment: Jonathan Poole is promoted to Executive Vice President and Chief Financial Officer, effective January 1, 2027.
• Transition: Charles F. Wagner, Jr. will step down as CFO but will remain Executive Vice President and Chief Operating Officer.
• Compensation: Mr. Poole's new employment agreement includes an annual base salary of $750,000 and a target annual bonus of 90% of his base salary.